[1]LIU X F，DAI Q L，YE R D，et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion（BEST）：an open-label，randomised controlled trial[J]. Lancet Neurol，2020，19（2）：115-122.
[2]LANGEZAAL LCM，VAN DER HOEVEN EJRJ，MONT’ALVERNE FJA，et al. Endovascular therapy for stroke due to basilar-artery occlusion[J]. N Engl J Med，2021，384（20）：1910-1920.
[3]JOVIN T G，LI C H，WU L F，et al. Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion[J]. N Engl J Med，2022，387（15）：1373-1384.
[4]TAO C R，NOGUEIRA R G，ZHU Y Y，et al. Trial of endovascular treatment of acute basilar-artery occlusion[J]. N Engl J Med，2022，387（15）：1361-1372.
[5]SARRAJ A，GROTTA J C，PUJARA D K，et al. Triage imaging and outcome measures for large core stroke thrombectomy - a systematic review and meta-analysis[J]. J Neurointerv Surg，2020，12（12）：1172-1179.
[6]YOSHIMURA S，SAKAI N，YAMAGAMI H，et al. Endovascular therapy for acute stroke with a large ischemic region[J]. N Engl J Med，2022，386（14）：1303-1313.
[7] NIE X M，LENG X Y，MIAO Z R，et al. Clinically ineffective reperfusion after endovascular therapy in acute ischemic stroke[J]. Stroke，2023，54（3）：873-881.
[8]XIE Y，OPPENHEIM C，GUILLEMIN F，et al. Pretreatment lesional volume impacts clinical outcome and thrombectomy efficacy[J]. Ann Neurol，2018，83（1）：178-185.
[9]OSPEL J M，HILL M D，DEMCHUK A，et al. Clinical impact of EVT with failed reperfusion in patients with acute ischemic stroke：results from the ESCAPE and ESCAPE-NA1 trials[J]. Neuroradiology，2021，63（11）：1883-1889.
[10]POWERS W J，RABINSTEIN A A，ACKERSON T，et al. Guidelines for the early management of patients with acute ischemic stroke：2019 update to the 2018 guidelines for the early management of acute ischemic stroke：a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J/OL]. Stroke，2019，50（12）：e344-e418[2023-02-02]. https://doi.org/10.1161/STR.0000000000000211.
[11]GUO Y J，LIN Y P，TANG Y F，et al. Safety and efficacy of early antiplatelet therapy in acute ischemic stroke patients receiving endovascular treatment：a systematic review and meta-analysis[J/OL]. J Clin Neurosci，2019，66：45-50[2023-02-02]. https://doi.org/10.1016/j.jocn.2019.05.028.
[12]YANG M，HUO X C，GAO F，et al. Safety and efficacy of heparinization during mechanical thrombectomy in acute ischemic stroke[J/OL]. Front Neurol，2019，10：299[2023-02-02]. https://doi.org/10.3389/fneur.2019.00299.
[13]BERGE E，WHITELEY W，AUDEBERT H，et al. European Stroke Organisation（ESO）guidelines on intravenous thrombolysis for acute ischaemic stroke[J]. Eur Stroke J，2021，6（1）：1-62.
[14]VAN DER STEEN W，VAN DE GRAAF R A，CHALOS V，et al. Safety and efficacy of aspirin，unfractionated heparin，both，or neither during endovascular stroke treatment（MR CLEAN-MED）：an open-label，multicentre，randomised controlled trial[J]. Lancet，2022，399（10329）：1059-1069.
[15]ALMEKHLAFI M A，COUTTS S B. Anti-thrombotics cause harm in the setting of stroke thrombectomy[J]. Lancet，2022，399（10329）：1025-1026.
[16]CANNON C P，WEINTRAUB W S，DEMOPOULOS L A，et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein Ⅱb/Ⅲa inhibitor tirofiban[J]. N Engl J Med，2001，344（25）：1879-1887.
[17]VAN'T HOF A W，TEN BERG J，HEESTERMANS T，et al. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty（On-TIME 2）：a multicentre，double-blind，randomised controlled trial[J]. Lancet，2008，372（9638）：537-546.
[18]CURA F A，BHATT D L，LINCOFF A M，et al.
Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein Ⅱb/Ⅲa inhibition in complex atherosclerotic lesions[J]. Circulation，2000，102（1）：28-34.
[19]QIU Z M，LI F L，SANG H F，et al. Effect of intravenous tirofiban vs placebo before endovascular thrombectomy on functional outcomes in large vessel occlusion stroke：the RESCUE BT randomized clinical trial[J]. JAMA，2022，328（6）：543-553.
[20]MULDER M J H L，ERGEZEN S，LINGSMA H F，et al. Baseline blood pressure effect on the benefit and safety of intra-arterial treatment in MR CLEAN（Multicenter randomized clinical trial of endovascular treatment of acute ischemic stroke in the Netherlands）[J]. Stroke，2017，48（7）：1869-1876.
[21]YANG P F，SONG L L，ZHANG Y W，et al. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke（ENCHANTED2/MT）：a multicentre，open-label，blinded-endpoint，randomised controlled trial[J]. Lancet，2022，400（10363）：1585-1596.
[22]CZOSNYKA M，SMIELEWSKI P，KIRKPATRICK P，et al. Continuous assessment of the cerebral vasomotor reactivity in head injury[J]. Neurosurgery，1997，41（1）：11-19.
[23]CARNEY N，TOTTEN A M，O'REILLY C，et al. Guidelines for the management of severe traumatic brain injury，fourth edition[J]. Neurosurgery，2017，80（1）：6-15.
[24]TAS J，BEQIRI E，VAN KAAM R C，et al. Targeting autoregulation-guided cerebral perfusion pressure after traumatic brain injury（COGiTATE）：a feasibility randomized controlled clinical trial[J]. J Neurotrauma，2021，38（20）：2790-2800.
[25]SANDRONI C，CRONBERG T，SEKHON M. Brain injury after cardiac arrest：pathophysiology，treatment，and prognosis[J]. Intensive Care Med，2021，47（12）：1393-1414.
[26]RUIJTER B J，KEIJZER H M，TJEPKEMA-CLOOSTERMANS M C，et al. Treating rhythmic and periodic EEG patterns in comatose survivors of cardiac arrest[J]. N Engl J Med，2022，386（8）：724-734.
[27] KJAERGAARD J，SCHMIDT H，MØLLER J E，et al. The "blood pressure and oxygenation targets in post resuscitation care，a randomized clinical trial"：design and statistical analysis plan[J]. Trials，2022，23（1）：177.
[28]KJAERGAARD J，MØLLER J E，SCHMIDT H，et al. Blood-pressure targets in comatose survivors of cardiac arrest[J]. N Engl J Med，2022，387（16）：1456-1466.
[29]SCHMIDT H，KJAERGAARD J，HASSAGER C，et al. Oxygen targets in comatose survivors of cardiac arrest[J]. N Engl J Med，2022，387（16）：1467-1476.
[30]ZHAO J J，YUAN F，SONG C G，et al.Safety and efficacy of three enteral feeding strategies in patients with severe stroke in China（OPENS）：a multicentre，prospective，randomised，open-label，blinded-endpoint trial[J]. Lancet Neurol，2022，21（4）：319-328.
[31]BÖSEL J，SCHILLER P，HOOK Y，et al. Stroke-related early tracheostomy versus prolonged orotracheal intubation in neurocritical care trial（SETPOINT）：a randomized pilot trial[J]. Stroke，2013，44（1）：21-28.
[32]BÖSEL J，NIESEN W D，SALIH F，et al.Effect of early vs standard approach to tracheostomy on functional outcome at 6 months among patients with severe stroke receiving mechanical ventilation：the SETPOINT2 randomized clinical trial[J]. JAMA，2022，327（19）：1899-1909.
[33]HORN C M，SUN C H，NOGUEIRA R G，et al. Endovascular reperfusion and cooling in cerebral acute ischemia（ReCCLAIM I）[J]. J Neurointerv Surg，2014，6（2）：91-95.
[34]LYDEN P，HEMMEN T，GROTTA J，et al. Results of the ICTuS 2 trial（intravascular cooling in the treatment of stroke 2）[J]. Stroke，2016，47（12）：2888-2895.
[35]LEVY B，GIRERD N，AMOUR J，et al. Effect of moderate hypothermia vs normothermia on 30-day mortality in patients with cardiogenic shock receiving venoarterial extracorporeal membrane oxygenation：a randomized clinical trial[J]. JAMA，2022，327（5）：442-453.
